[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Clinical Challenges in Otolaryngology
December 1999

Treatment of Stage III and IV Supraglottic CarcinomaShould Elderly Patients Undergo Standard Treatment Protocols?

Author Affiliations

From the Division of Otolaryngology, Department of Surgery, University of Louisville School of Medicine, Louisville, Ky.

 

KAREN H.CALHOUNMDRONALD B.KUPPERSMITHMD

Arch Otolaryngol Head Neck Surg. 1999;125(12):1402-1404. doi:10.1001/archotol.125.12.1402

The treatment of a T3, N1, M0 supraglottic carcinoma should be the same in an otherwise healthy 80-year-old patient as in an otherwise healthy 40-year-old patient.

Otolaryngologists are increasingly faced with challenges presented by the "graying" of our patient population. The fastest growing element of our population comprises individuals who are older than 65 years. Furthermore, the proportion of deaths due to cancer in the aged has been increasing in developed countries, including the United States.1 There has been debate among oncologists regarding the need to modify aggressive treatment protocols with regard to patient age. The intention of this article is to bring into focus the impact of aging on the treatment of locoregionally advanced squamous cell carcinoma of the supraglottic larynx.

First Page Preview View Large
First page PDF preview
First page PDF preview
×